Stockholm, December 7, 2011 — NASDAQ OMX (NASDAQ: NDAQ) announces that trading in XCounter AB (short name: XCT) shares will commence today, December 7, on First North at NASDAQ OMX Stockholm. Prior to this, XCounter was listed on AIM in London, the London Stock Exchange growth market. XCounter belongs to the Health Care sector and is the 15th company to be admitted to trading on First North in 2011.
Based on over 10 years of experience, XCounter develops and supplies high performance X-ray detector solutions, providing superior image quality at minimal radiation dose, for applications in the medical, dental and industrial area in a global market. Headquartered in Stockholm, XCounter employs 32 people in its facilities in Sweden and Finland. For more information see www.xcounter.se.
Jenny Rosberg, Senior Vice President at NASDAQ OMX said, “We are very pleased that XCounter chose to move its listing to First North, one of Europe’s leading market places for growth companies. Many of our First North listings this year are switches from other growth markets, which is a testament to the strong liquidity and broad investor reach that we can offer our listed companies.”
XCounter’s CEO, Mikael Strindlund, commented, “A listing on First North is in the best interest for the company as well as its shareholders. A request from our shareholders is hereby fulfilled. The move will result in substantial annual cost savings as well as reduce listing complexity. As a Swedish company, a greater visibility in Scandinavia will also expose us to an increased number of shareholders.”
XCounter has appointed Mangold Fondkommission as Certified Adviser.
Cautionary Note Regarding Forward-Looking Statements
The matters described herein contain forward-looking statements that are made under the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements include, but are not limited to, statements about NASDAQ OMX's products and offerings. We caution that these statements are not guarantees of future performance. Actual results may differ materially from those expressed or implied in the forward-looking statements. Forward-looking statements involve a number of risks, uncertainties or other factors beyond NASDAQ OMX's control. These factors include, but are not limited to factors detailed in NASDAQ OMX's annual report on Form 10-K, and periodic reports filed with the U.S. Securities and Exchange Commission. We undertake no obligation to release any revisions to any forward-looking statements.
NASDAQ OMX Media contact:
Carl Norell +46 8 405 66 39